Literature DB >> 22860194

Transformation of Pro-Leu-Gly-NH2 peptidomimetic positive allosteric modulators of the dopamine D2 receptor into negative modulators.

Swapna Bhagwanth1, Satyendra Mishra, Ritesh Daya, Jordan Mah, Ram K Mishra, Rodney L Johnson.   

Abstract

The synthesis of dimethyl derivatives of 5.6.5 spiro bicyclic lactam Pro-Leu-Gly-NH(2) peptidomimetics was carried out to test the hypothesis that by placing methyl groups on the β-methylene carbon of the thiazolidine ring steric bulk would be introduced into the topological space that the β-methylene carbon is believed to occupy in the negative allosteric modulators of the dopamine D(2) receptor. With such a modification, a positive allosteric modulator would be converted into a negative allosteric modulator. This hypothesis was shown to be correct as 3a and 4a where found to be negative allosteric modulators, whereas their unmethylated derivatives were positive allosteric modulators of the dopamine D(2) receptor.

Entities:  

Keywords:  Allosteric modulation; Pro-Leu-Gly-NH2; dopamine D2 receptor; peptidomimetic; spiro bicyclic lactam

Mesh:

Substances:

Year:  2012        PMID: 22860194      PMCID: PMC3389495          DOI: 10.1021/cn200096u

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  18 in total

1.  Modulation of dopaminergic neurotransmission in the 6-hydroxydopamine lesioned rotational model by peptidomimetic analogues of L-prolyl-L-leucyl-glycinamide.

Authors:  M C Ott; R K Mishra; R L Johnson
Journal:  Brain Res       Date:  1996-10-21       Impact factor: 3.252

2.  Synthesis and calcium antagonistic activity of (+)-(R)- and (-)-(S)-3-acetyl-2-[5-methoxy-2-[4-[N-methyl-N-(3,4,5- trimethoxyphenethyl)amino]butoxy]phenyl]benzothiazoline hydrochloride.

Authors:  M Fujita; A Ota; S Ito; K Yamamoto; Y Kawashima; T Iso; J Iwao
Journal:  Chem Pharm Bull (Tokyo)       Date:  1990-04       Impact factor: 1.645

3.  Potent angiotensin II antagonists with non-beta-branched amino acids in position 5.

Authors:  J Samanen; D Narindray; T Cash; E Brandeis; W Adams; T Yellin; D Eggleston; C DeBrosse; D Regoli
Journal:  J Med Chem       Date:  1989-02       Impact factor: 7.446

4.  Design, synthesis, and dopamine receptor modulating activity of spiro bicyclic peptidomimetics of L-prolyl-L-leucyl-glycinamide.

Authors:  E M Khalil; W H Ojala; A Pradhan; V D Nair; W B Gleason; R K Mishra; R L Johnson
Journal:  J Med Chem       Date:  1999-02-25       Impact factor: 7.446

5.  Pro-Leu-glycinamide and its peptidomimetic, PAOPA, attenuate haloperidol induced vacuous chewing movements in rat: A model of human tardive dyskinesia.

Authors:  S Sharma; P Paladino; J Gabriele; H Saeedi; P Henry; M Chang; R K Mishra; R L Johnson
Journal:  Peptides       Date:  2003-02       Impact factor: 3.750

6.  Modulation of dopamine receptor agonist-induced rotational behavior in 6-OHDA-lesioned rats by a peptidomimetic analogue of Pro-Leu-Gly-NH2 (PLG).

Authors:  R K Mishra; E R Marcotte; A Chugh; C Barlas; D Whan; R L Johnson
Journal:  Peptides       Date:  1997       Impact factor: 3.750

7.  Characterization of high-affinity dopamine D2 receptors and modulation of affinity states by guanine nucleotides in cholate-solubilized bovine striatal preparations.

Authors:  S M Kazmi; J Ramwani; L K Srivastava; G Rajakumar; G M Ross; M Cullen; R K Mishra
Journal:  J Neurochem       Date:  1986-11       Impact factor: 5.372

8.  Design and synthesis of some substituted 1H-pyrazolyl-oxazolidines or 1H-pyrazolyl-thiazolidines as anti-inflammatory-antimicrobial agents.

Authors:  Adnan A Bekhit; Hesham T Y Fahmy
Journal:  Arch Pharm (Weinheim)       Date:  2003-04       Impact factor: 3.751

9.  Interaction of L-prolyl-L-leucyl glycinamide with dopamine D2 receptor: evidence for modulation of agonist affinity states in bovine striatal membranes.

Authors:  L K Srivastava; S B Bajwa; R L Johnson; R K Mishra
Journal:  J Neurochem       Date:  1988-03       Impact factor: 5.372

10.  Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of L-prolyl-L-leucyl-glycinamide (PLG).

Authors:  G Rajakumar; F Naas; R L Johnson; S Chiu; K L Yu; R K Mishra
Journal:  Peptides       Date:  1987 Sep-Oct       Impact factor: 3.750

View more
  6 in total

1.  Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors.

Authors:  J Robert Lane; Pavel Chubukov; Wei Liu; Meritxell Canals; Vadim Cherezov; Ruben Abagyan; Raymond C Stevens; Vsevolod Katritch
Journal:  Mol Pharmacol       Date:  2013-09-10       Impact factor: 4.436

2.  Drug Design Strategies for GPCR Allosteric Modulators.

Authors:  P Jeffrey Conn; Scott D Kuduk; Darío Doller
Journal:  Annu Rep Med Chem       Date:  2012       Impact factor: 1.059

Review 3.  Development of allosteric modulators of GPCRs for treatment of CNS disorders.

Authors:  Hilary Highfield Nickols; P Jeffrey Conn
Journal:  Neurobiol Dis       Date:  2013-09-27       Impact factor: 5.996

Review 4.  Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.

Authors:  Eric A Wold; Jianping Chen; Kathryn A Cunningham; Jia Zhou
Journal:  J Med Chem       Date:  2018-08-28       Impact factor: 7.446

5.  Development of peptidomimetic ligands of Pro-Leu-Gly-NH(2) as allosteric modulators of the dopamine D(2) receptor.

Authors:  Swapna Bhagwanth; Ram K Mishra; Rodney L Johnson
Journal:  Beilstein J Org Chem       Date:  2013-01-30       Impact factor: 2.883

6.  Effects of the dopamine D2 allosteric modulator, PAOPA, on the expression of GRK2, arrestin-3, ERK1/2, and on receptor internalization.

Authors:  Dipannita Basu; Yuxin Tian; Jayant Bhandari; Jian Ru Jiang; Patricia Hui; Rodney L Johnson; Ram K Mishra
Journal:  PLoS One       Date:  2013-08-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.